Specifically, TRIM24 promotes p53 ubiquitination and proteasome-dependent degradation [47], and also interacts with chromatin and estrogen receptor to induce target genes controlling cell division and carcinogenesis in breast cancer [41]. Here, TP53 is linked to breast cancer.